466 related articles for article (PubMed ID: 17551011)
1. Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors.
Kirson ED; Dbalý V; Tovarys F; Vymazal J; Soustiel JF; Itzhaki A; Mordechovich D; Steinberg-Shapira S; Gurvich Z; Schneiderman R; Wasserman Y; Salzberg M; Ryffel B; Goldsher D; Dekel E; Palti Y
Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10152-7. PubMed ID: 17551011
[TBL] [Abstract][Full Text] [Related]
2. Response patterns of recurrent glioblastomas treated with tumor-treating fields.
Vymazal J; Wong ET
Semin Oncol; 2014 Oct; 41 Suppl 6():S14-24. PubMed ID: 25213870
[TBL] [Abstract][Full Text] [Related]
3. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality.
Stupp R; Wong ET; Kanner AA; Steinberg D; Engelhard H; Heidecke V; Kirson ED; Taillibert S; Liebermann F; Dbalý V; Ram Z; Villano JL; Rainov N; Weinberg U; Schiff D; Kunschner L; Raizer J; Honnorat J; Sloan A; Malkin M; Landolfi JC; Payer F; Mehdorn M; Weil RJ; Pannullo SC; Westphal M; Smrcka M; Chin L; Kostron H; Hofer S; Bruce J; Cosgrove R; Paleologous N; Palti Y; Gutin PH
Eur J Cancer; 2012 Sep; 48(14):2192-202. PubMed ID: 22608262
[TBL] [Abstract][Full Text] [Related]
4. Tumor treating fields: a novel treatment modality and its use in brain tumors.
Hottinger AF; Pacheco P; Stupp R
Neuro Oncol; 2016 Oct; 18(10):1338-49. PubMed ID: 27664860
[TBL] [Abstract][Full Text] [Related]
5. A pilot study with very low-intensity, intermediate-frequency electric fields in patients with locally advanced and/or metastatic solid tumors.
Salzberg M; Kirson E; Palti Y; Rochlitz C
Onkologie; 2008 Jul; 31(7):362-5. PubMed ID: 18596382
[TBL] [Abstract][Full Text] [Related]
6. Exploring the efficacy of tumor electric field therapy against glioblastoma: An in vivo and in vitro study.
Wu H; Yang L; Liu H; Zhou D; Chen D; Zheng X; Yang H; Li C; Chang J; Wu A; Wang Z; Ren N; Lv S; Liu Y; Jia M; Lu J; Liu H; Sun G; Liu Z; Liu J; Chen L
CNS Neurosci Ther; 2021 Dec; 27(12):1587-1604. PubMed ID: 34710276
[TBL] [Abstract][Full Text] [Related]
7. Characterization and management of dermatologic adverse events with the NovoTTF-100A System, a novel anti-mitotic electric field device for the treatment of recurrent glioblastoma.
Lacouture ME; Davis ME; Elzinga G; Butowski N; Tran D; Villano JL; DiMeglio L; Davies AM; Wong ET
Semin Oncol; 2014 Jun; 41 Suppl 4():S1-14. PubMed ID: 24794308
[TBL] [Abstract][Full Text] [Related]
8. Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo.
Giladi M; Weinberg U; Schneiderman RS; Porat Y; Munster M; Voloshin T; Blatt R; Cahal S; Itzhaki A; Onn A; Kirson ED; Palti Y
Semin Oncol; 2014 Oct; 41 Suppl 6():S35-41. PubMed ID: 25213867
[TBL] [Abstract][Full Text] [Related]
9. Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies.
Mittal S; Klinger NV; Michelhaugh SK; Barger GR; Pannullo SC; Juhász C
J Neurosurg; 2018 Feb; 128(2):414-421. PubMed ID: 28298023
[TBL] [Abstract][Full Text] [Related]
10. NovoTTF-100A: a new treatment modality for recurrent glioblastoma.
Fonkem E; Wong ET
Expert Rev Neurother; 2012 Aug; 12(8):895-9. PubMed ID: 22708931
[TBL] [Abstract][Full Text] [Related]
11. Computed modeling of alternating electric fields therapy for recurrent glioblastoma.
Lok E; Hua V; Wong ET
Cancer Med; 2015 Nov; 4(11):1697-9. PubMed ID: 26311253
[TBL] [Abstract][Full Text] [Related]
12. Rationale and Background on Tumor-Treating Fields for Glioblastoma.
Schwartz MA; Onuselogu L
Clin J Oncol Nurs; 2016 Oct; 20(5 Suppl):S20-4. PubMed ID: 27668387
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor position, conductivity distribution and tissue homogeneity on the distribution of tumor treating fields in a human brain: A computer modeling study.
Korshoej AR; Hansen FL; Thielscher A; von Oettingen GB; Sørensen JCH
PLoS One; 2017; 12(6):e0179214. PubMed ID: 28604803
[TBL] [Abstract][Full Text] [Related]
14. Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma.
Di Sebastiano AR; Deweyert A; Benoit S; Iredale E; Xu H; De Oliveira C; Wong E; Schmid S; Hebb MO
Sci Rep; 2018 May; 8(1):7301. PubMed ID: 29740075
[TBL] [Abstract][Full Text] [Related]
15. The effects of alternating electric fields in glioblastoma: current evidence on therapeutic mechanisms and clinical outcomes.
Rehman AA; Elmore KB; Mattei TA
Neurosurg Focus; 2015 Mar; 38(3):E14. PubMed ID: 25727223
[TBL] [Abstract][Full Text] [Related]
16. Clinical practice experience with NovoTTF-100A™ system for glioblastoma: The Patient Registry Dataset (PRiDe).
Mrugala MM; Engelhard HH; Dinh Tran D; Kew Y; Cavaliere R; Villano JL; Annenelie Bota D; Rudnick J; Love Sumrall A; Zhu JJ; Butowski N
Semin Oncol; 2014 Oct; 41 Suppl 6():S4-S13. PubMed ID: 25213869
[TBL] [Abstract][Full Text] [Related]
17. Tumor treating fields: concept, evidence and future.
Pless M; Weinberg U
Expert Opin Investig Drugs; 2011 Aug; 20(8):1099-106. PubMed ID: 21548832
[TBL] [Abstract][Full Text] [Related]
18. Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo.
Voloshin T; Munster M; Blatt R; Shteingauz A; Roberts PC; Schmelz EM; Giladi M; Schneiderman RS; Zeevi E; Porat Y; Bomzon Z; Urman N; Itzhaki A; Cahal S; Kirson ED; Weinberg U; Palti Y
Int J Cancer; 2016 Dec; 139(12):2850-2858. PubMed ID: 27561100
[TBL] [Abstract][Full Text] [Related]
19. Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields.
Chang E; Pohling C; Beygui N; Patel CB; Rosenberg J; Ha DH; Gambhir SS
J Neurooncol; 2017 Sep; 134(2):259-268. PubMed ID: 28681243
[TBL] [Abstract][Full Text] [Related]
20. A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling.
Wenger C; Miranda PC; Salvador R; Thielscher A; Bomzon Z; Giladi M; Mrugala MM; Korshoej AR
IEEE Rev Biomed Eng; 2018; 11():195-207. PubMed ID: 29993870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
